Ys Biopharma Co Ltd. (YS) | Rumor.io

Ys Biopharma

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)100%

Price to earnings ratio-0.02

Market capitalization12.6M

Earnings per share-3.05

Dividend yield (TTM)—

Revenue (annual)687.2M

Net income (annual)-145.5M

Social

What share of all stock conversation is about YS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% 0	0% 0

Apr 27

YS Biopharma Co., Ltd. is mentioned in a post about a petrol and diesel shortage in Andhra Pradesh.
The post mentions YS Jagan Mohan Reddy, which may be a reference to a government official or a notable figure in the region.
The post does not provide any specific information about the company's financial performance or stock price.

Generated by AI

Sentiment

Of the messages about YS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	20% -78.11
Bearish	—	—	—	80% +78.11

Bullish· Aug 25

$YS has significant buying power, with 8 figures of small cap buying power, allowing it to move markets in its favor.
Retail traders have been able to drive $YS to a +70% gain overnight, with the stock showing no signs of slowing down.
$YS is a Covid play with strong momentum, having gapped up by as much as +64% and leading the Prism MarketView Biotech index, with insiders purchasing shares.

Bearish· Jun 13

$YS has loose corporate governance rules, with direct ties to the PRC, and has been involved in a private placement with low-priced shares and tiered lock-up language.
The company has been associated with short-selling and manipulation, with some individuals promoting the stock's decline and others accusing it of being a "Chinese fire drill".
$YS has experienced significant price drops, including a 12.57% decline to $1.53, with some users predicting further declines and others attributing the drops to technical analysis and market manipulation.

Generated by AI

Topics

Of the messages about YS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	0%	0%	0%	0.94%
Announcements	100%	100%	100%	4.72%
Controversies	0%	0%	0%	27.36%
Earnings	0%	0%	0%	0%
Macro	0%	0%	0%	66.98%
Technical Analysis	0%	0%	0%	0%

Community

Of the messages about YS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	20%	0.98%
Newcomers	0%	0%	80%	99.02%

Regulars· Aug 25

$YS Biopharma has seen a significant price increase, up 71.1% pre-market, following the announcement of company officers purchasing shares.
Regulars are focused on the potential for $YS to continue its upward trend, with some predicting it could "take off" in the near future.
The company's status as a Covid-19 play is being highlighted by regulars, with one noting it as a key factor in its current performance.

Newcomers· Aug 27

The newcomers are primarily buying and selling $YS with varying amounts, ranging from $5.96K to $129.23K.
There are multiple instances of Cupseyy and cented buying and selling $YS, indicating that these users are actively engaged with the asset.
The users are tracking their transactions in real-time, with some transactions occurring at specific price points, such as $13.87K and $14.53K.

Generated by AI

Also Discussed

Investors talking about YS also mention

#	Name	Attention
1	Dogwood Therapeutics Inc.VIRI	0%0
2	Hub Cyber Security Ltd.HUBC	0%+0
3	NVOS - Novo Integrated Sciences, Inc.	——
4	PaxMedica Inc.PXMD	0%0
5	Cosmos Health Inc.COSM	0.02%+0.01
6	CYTO - Altamira Therapeutics Ltd.	——
7	KAL - Kalera Public Limited Company	——
8	Allarity Therapeutics Inc.ALLR	0%-0.01
9	TRKA - Troika Media Group, Inc.	——
10	Ocean Biomedical Inc.OCEA	0%0

Ys Biopharma Co Ltd.

Healthcare
Biotechnology

YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

Website

Location

Building No. 2

Beijing, 102629

China

Social

What share of all stock conversation is about YS?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% 0	0% 0	0% 0

Apr 27

YS Biopharma Co., Ltd. is mentioned in a post about a petrol and diesel shortage in Andhra Pradesh.
The post mentions YS Jagan Mohan Reddy, which may be a reference to a government official or a notable figure in the region.
The post does not provide any specific information about the company's financial performance or stock price.

Generated by AI

Sentiment

Of the messages about YS that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	20% -78.11
Bearish	—	—	—	80% +78.11

Bullish· Aug 25

$YS has significant buying power, with 8 figures of small cap buying power, allowing it to move markets in its favor.
Retail traders have been able to drive $YS to a +70% gain overnight, with the stock showing no signs of slowing down.
$YS is a Covid play with strong momentum, having gapped up by as much as +64% and leading the Prism MarketView Biotech index, with insiders purchasing shares.

Bearish· Jun 13

$YS has loose corporate governance rules, with direct ties to the PRC, and has been involved in a private placement with low-priced shares and tiered lock-up language.
The company has been associated with short-selling and manipulation, with some individuals promoting the stock's decline and others accusing it of being a "Chinese fire drill".
$YS has experienced significant price drops, including a 12.57% decline to $1.53, with some users predicting further declines and others attributing the drops to technical analysis and market manipulation.

Generated by AI

Topics

Of the messages about YS that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	0%	0%	0%	0.94%
Announcements	100%	100%	100%	4.72%
Controversies	0%	0%	0%	27.36%
Earnings	0%	0%	0%	0%
Macro	0%	0%	0%	66.98%
Technical Analysis	0%	0%	0%	0%

Community

Of the messages about YS, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	100%	20%	0.98%
Newcomers	0%	0%	80%	99.02%

Regulars· Aug 25

$YS Biopharma has seen a significant price increase, up 71.1% pre-market, following the announcement of company officers purchasing shares.
Regulars are focused on the potential for $YS to continue its upward trend, with some predicting it could "take off" in the near future.
The company's status as a Covid-19 play is being highlighted by regulars, with one noting it as a key factor in its current performance.

Newcomers· Aug 27

The newcomers are primarily buying and selling $YS with varying amounts, ranging from $5.96K to $129.23K.
There are multiple instances of Cupseyy and cented buying and selling $YS, indicating that these users are actively engaged with the asset.
The users are tracking their transactions in real-time, with some transactions occurring at specific price points, such as $13.87K and $14.53K.

Generated by AI

Ys Biopharma

Social

Apr 27

Sentiment

Bullish· Aug 25

Bearish· Jun 13

Topics

Community

Regulars· Aug 25

Newcomers· Aug 27

Also Discussed

Ys Biopharma Co Ltd.

Company Information

Location

Also Discussed

Social

Apr 27

Sentiment

Bullish· Aug 25

Bearish· Jun 13

Topics

Community

Regulars· Aug 25

Newcomers· Aug 27